Mark Bodmer - May 7, 2023 Form 4 Insider Report for Evelo Biosciences, Inc. (EVLO)

Role: CSO, President of R&D
Signature: /s/ Marella Thorell, Attorney-in-Fact for Mark Bodmer
Stock symbol: EVLO
Transactions as of: May 7, 2023
Transactions value $: $0
Form type: 4
Date filed: 5/9/2023, 04:08 PM
Previous filing: Feb 9, 2023
Next filing: May 10, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EVLO	Common Stock	Options Exercise		+133K	+60.05%		353K	May 7, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EVLO	Restricted Stock Units	Options Exercise	$0	-133K	-25%	$0.00	398K	May 7, 2023	Common Stock	133K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
F2	The RSUs vest in four (4) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the first anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. These RSUs have no expiration date.